Physician

Shannon Haenel, D.O.

According to 2025 Medicare claims, Shannon Haenel, D.O. (NPI: 1811124365) practices hematology/oncology in the Wilmington, NC market, with the plurality of this provider's patient population coming from New Hanover, NC. This provider's primary affiliated billing organization is WILMINGTON HEALTH PLLC (NPI: 1881632339; TIN: 561980160) and primary practice location at 28401-7684. Haenel is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645) and Physicians Healthcare Collaborative (ACO ID: D0068), participating under both the MSSP and REACH models.

Haenel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 247 traditional Medicare patients, billed 57,197 HCPCS/CPT codes, and received $717,955 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 326 prescription claims across 130 beneficiaries totaling $698,765 in drug costs, led by Tagrisso (Osimertinib Mesylate). 2021 DME data shows 12 claims. Open Payments data shows 73 records totaling $1,450. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $998,775 to $717,955. In contrast, Part D prescription costs have moved sharply higher in recent years, from $2,611 to $698,765. For DME billing, this smaller-volume category did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	414	211,108	$998,775
2017	728	313,389	$1,782,823
2018	252	719	$73,017
2019	330	1,152	$89,110
2020	322	1,027	$76,987
2021	337	1,058	$95,340
2022	343	1,047	$91,228
2023	312	881	$74,698
2024	247	57,197	$717,955

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	36	$2,611
2016	33	157	$67,145
2017	49	259	$127,591
2018	77	288	$132,122
2019	85	509	$347,774
2020	104	733	$514,582
2021	114	881	$1,216,971
2022	114	905	$2,084,279
2023	127	934	$2,114,009
2024	130	326	$698,765

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	77	$3,003
2018	N/R	N/R	N/R
2019	N/R	19	$1,092
2020	N/R	30	$1,024
2021	N/R	12	$347
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	91	91	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	106	132	$99
82728	Ferritin (blood protein) level	68	120	$13
36415	Insertion of needle into vein for collection of blood sample	123	341	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	113	317	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	15	450	$240,643
Tamoxifen Citrate	Tamoxifen Citrate	39	3,520	$1,240
Letrozole	Letrozole	37	2,941	$805
Anastrozole	Anastrozole	21	1,890	$591
Hydroxyurea	Hydroxyurea	23	1,398	$507

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	73	$1,450	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shannon Haenel, D.O.?

Tedicare shows public-source Medicare data for Shannon Haenel, D.O. (NPI 1811124365), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shannon Haenel, D.O. have ACO affiliation data?

Shannon Haenel, D.O. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645) and Physicians Healthcare Collaborative (REACH, ACO ID D0068).

What billing organization is linked to Shannon Haenel, D.O.?

Shannon Haenel, D.O. is linked to WILMINGTON HEALTH PLLC (billing NPI 1881632339) in the available physician profile data.

Does Shannon Haenel, D.O. have Open Payments data?

Shannon Haenel, D.O. has 73 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.